BioNTech SE - ADR

NASDAQ:BNTX   4:00:00 PM EDT
123.60
-4.60 (-3.59%)
: $122.81 -0.79 (-0.64%)
Business Deals, Products

Biontech And Fosun Pharma To Supply China With MRNA-Based COVID-19 Vaccine

Published: 12/16/2020 08:12 GMT
BioNTech SE - ADR (BNTX) - Biontech and Fosun Pharma to Supply China With Mrna-based Covid-19 Vaccine.
Supply Agreement Reflects Both Companies' Shared Commitment and Efforts to Achieve Vaccine Accessibility and Affordability in China.
Local Phase 2 Clinical Trial of Mrna Covid-19 Vaccine Candidate Bnt162b2 is On-going in Jiangsu, China.